Augmented medial rectus recession versus botulinum toxin therapy for acute acquired comitant esotropia: analysis of outcomes and recurrence predictors

Yueping Li, Tengyue Zhang, Juan Ding, Rui Hao, Liping Chen, Fang Xie, Ping Zhu, Wei Zhang

Open source

DOI
10.1136/bjo-2025-328201
Published
2025-10-01
Container
British Journal of Ophthalmology
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bjo-2025-328201,
  title = {Augmented medial rectus recession versus botulinum toxin therapy for acute acquired comitant esotropia: analysis of outcomes and recurrence predictors},
  author = {Yueping Li and Tengyue Zhang and Juan Ding and Rui Hao and Liping Chen and Fang Xie and Ping Zhu and Wei Zhang},
  year = {2025},
  journal = {British Journal of Ophthalmology},
  doi = {10.1136/bjo-2025-328201},
  url = {https://doi.org/10.1136/bjo-2025-328201}
}

RIS

TY  - JOUR
TI  - Augmented medial rectus recession versus botulinum toxin therapy for acute acquired comitant esotropia: analysis of outcomes and recurrence predictors
AU  - Yueping Li
AU  - Tengyue Zhang
AU  - Juan Ding
AU  - Rui Hao
AU  - Liping Chen
AU  - Fang Xie
AU  - Ping Zhu
AU  - Wei Zhang
PY  - 2025
JO  - British Journal of Ophthalmology
DO  - 10.1136/bjo-2025-328201
UR  - https://doi.org/10.1136/bjo-2025-328201
ER  - 

APA

Li, Y., Zhang, T., Ding, J., Hao, R., Chen, L., Xie, F., Zhu, P., & Zhang, W. (2025). Augmented medial rectus recession versus botulinum toxin therapy for acute acquired comitant esotropia: analysis of outcomes and recurrence predictors. British Journal of Ophthalmology. https://doi.org/10.1136/bjo-2025-328201

Source records